New Pancreatic Cancer Drug Transforms Lives After 50 Years

A breakthrough drug called daraxonrasib is giving hope to pancreatic cancer patients after scientists spent nearly 50 years trying to target the KRAS mutation.

Patients like 36-year-old Leanna Stokes are living far longer than expected thanks to this medical breakthrough.